TMO Financial Facts

Income from Continuing Operations: 473.5M
Other Expense, Net: -113.2M
See Full Income Statement

Total current liabilities: 5.26B
Property, Plant and Equipment at Cost, Net: 2.6B
See Full Balance Sheet

Thermo Fisher Scientific, Inc. (TMO) Earnings

  |   Expand Research on TMO
Next EPS Date 7/22/21 *Est. EPS Growth Rate +145.2% *Last Qtr.
Average EPS % Beat Rate +22.2% Revenue Growth Rate +59.1% *Last Qtr.
Average % Move 1-Wk after EPS -0.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/29/21 Q121 $7.21$6.65 +$0.56$9.91B$9.72B N/A Details
2/1/21 Q420 $7.09$6.29 +$0.80$10.55B$9.3B N/A Details
10/21/20 Q320 $5.63$4.31 +$1.32$8.52B$7.65B N/A Details
7/22/20 Q220 $3.89$2.84 +$1.05$6.92B$6.13B N/A Details
4/22/20 Q120 $2.94$2.79 +$0.15$6.23B$6.17B N/A Details
1/30/20 Q419 $3.55$3.54 +$0.01$6.83B$6.78B N/A Details
10/23/19 Q319 $2.94$2.87 +$0.07$6.27B$6.18B = Details
7/24/19 Q219 $3.04$3.00 +$0.04$6.32B$6.3B = Details